ABTL0812 AN AUTOPHAGY-ANTICANCER DRUG IN PHASE II CLINICAL TRIALS THAT INHIBITS PI3K/AKT/MTOR PATHWAY BY INDUCING TRIB3 EXPRESSION
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY（2017）
Key words
ABTL0812,autophagy,PI3K/Akt/mTOR pathway,Phase I/II,lung cancer,endometrial cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined